-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-09-15
The reference study identifies a CD28–ARS2 signaling axis that connects costimulation to alternative splicing of PKM, favoring PKM2 and enabling metabolic flexibility in activated CD8+ T cells. Its findings separate this splicing-dependent metabolic program from canonical CD28–PI3K signaling and link it to interferon-γ production and antitumor effector activity.
-
PXR Activation, Liver Regeneration, and CYP Activity
2026-09-15
This rat study shows that pregnane X receptor (PXR) activation can enlarge and regenerate the liver while selectively increasing CYP3A1/2 and CYP2C6/11 protein expression and metabolic activity. Its combined structural, functional, and pharmacokinetic design clarifies why liver growth after injury should not be interpreted independently of drug-metabolizing capacity.
-
Degarelix Acetate: From Receptor Blockade to Assays
2026-09-14
Degarelix acetate is a selective GnRH receptor antagonist with applications spanning pituitary hormone regulation and prostate cancer research. This guide translates its pharmacology and clinical evidence into better endpoint selection, exposure control, and assay design.
-
Reversine Workflow for Aurora Kinase Checkpoints
2026-09-14
Use Reversine to connect Aurora kinase perturbation with mitotic checkpoint behavior, proliferation, and apoptosis in cancer-cell assays. This practical workflow emphasizes solvent control, orthogonal readouts, and careful separation of Aurora-driven effects from the Plk1–p31comet–MCC mechanism.
-
Tiamulin Workflows for Veterinary Research
2026-09-13
Tiamulin (Thiamutilin) supports a practical bridge between isolate-level antimicrobial testing, veterinary pharmacology, and inflammation-focused cell assays. This guide turns susceptibility data, solvent constraints, PK/PD targets, and signaling readouts into reproducible workflows for pigs, poultry, and translational research.
-
Cytoskeleton-Dependent Autophagy Under Mechanical Stress
2026-09-12
The reference study shows that compression-induced autophagy in human cells depends strongly on cytoskeletal microfilaments, while microtubules provide a supporting role. By combining cytoskeletal polymerization perturbation with fluorescence imaging and western blotting, the work moves beyond correlation and identifies a structural requirement for mechanical-stress signaling.
-
In Vitro Drug Response Metrics in Cancer Research
2026-09-11
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a time-aware framework for separating proliferative arrest from cell killing, improving interpretation of in vitro drug-response experiments and translational cancer research workflows.
-
SFRP1, Wnt/β-Catenin, and Oral Submucous Fibrosis
2026-09-11
The reference study identifies SFRP1 as a potential regulator of oral submucous fibrosis by linking reduced neutrophil infiltration with suppression of Wnt/β-catenin signaling. Its combination of an arecoline-induced mouse model, SFRP1 overexpression, tissue analyses, and pathway-activation rescue experiments provides a mechanistic framework for studying inflammatory fibrosis.
-
Ruxolitinib Phosphate and Mitochondrial Signaling
2026-09-10
A translational perspective on how Ruxolitinib phosphate and INCB018424 connect JAK1/2 inhibition with STAT3-dependent mitochondrial dynamics, apoptosis, and pyroptosis in anaplastic thyroid carcinoma research.
-
SGC-CBP30 in LUAD Super-Enhancer Research
2026-09-10
SGC-CBP30 is a focused chemical probe for testing how CREBBP and EP300 bromodomain activity supports enhancer-driven transcription. This workflow connects chromatin occupancy, LINC01977 regulation, TGF-β/SMAD3 signaling, and tumor-cell phenotypes in lung adenocarcinoma research while clearly separating published findings from proposed experiments.
-
Epacadostat: From IDO1 Inhibition to Translation
2026-09-09
A translational framework for using Epacadostat (INCB024360) to connect IDO1 target engagement with immunometabolic, T-cell, and checkpoint-combination readouts.
-
Ruxolitinib Workflows for JAK-STAT Research
2026-09-09
Ruxolitinib (INCB018424) combines highly selective JAK1/JAK2 inhibition with practical applications in progenitor-cell assays, myelofibrosis research, oncogenic JAK2 fusion protein studies, and immune profiling. This guide translates its biochemical selectivity into reproducible workflows, spectral cytometry strategies, and troubleshooting decisions for bench researchers.
-
DiscoveryProbe Protease Inhibitor Library: Assay Logic
2026-09-08
The DiscoveryProbe Protease Inhibitor Library enables mechanism-aware protease inhibition studies beyond simple endpoint screening. This article translates the dynamic DdmDE defense-system findings into practical decisions for protease activity modulation, orthogonal readouts, and reproducible HTS and HCS workflows.
-
Nuclear cGAS, Chk2, and L1 Retrotransposition
2026-09-08
The reference study identifies nuclear cGAS as an active suppressor of LINE-1 retrotransposition rather than only a cytosolic DNA sensor. It defines a CHK2–cGAS–TRIM41 pathway that promotes ORF2p ubiquitination and degradation, linking DNA damage signaling to genome protection and suggesting testable implications for aging and cancer research.
-
Isradipine (Dynacirc) in Calcium Channel Research
2026-09-07
Isradipine (Dynacirc) provides a practical way to interrogate L-type calcium channel function across neuronal and vascular models. This article translates channel pharmacology into reproducible workflows for neuroprotection, vascular smooth muscle relaxation, hypertension research, and assay troubleshooting.